查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1632627

分子诊断市场规模、份额、趋势分析报告：按产品、按测试地点、按技术、按应用、按地区、细分市场预测，2025-2030

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location (Point of Care, Self-Test), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 269 Pages | 商品交期: 2-10个工作天内

价格

分子诊断市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球分子诊断市场规模将达到330.8亿美元，2025年至2030年复合年增长率为3.97%。

市场萎缩是由于对 COVID-19 分子检测的需求下降。然而，老年人口增加和对NGS等技术的需求增加等因素预计将推动市场成长。

分子诊断在传染病检查中发挥重要作用，因为它可以提供有效且快速的结果。因此，医院感染和感染疾病的日益普及预计将在预测期内推动市场。预计遗传病患病率和认识的提高将进一步加速市场成长。奈米生物技术、生物晶片和微射流这三种基本分子检测的小型化预计将提高诊断结果的准确性和特异性，并增加对分子诊断产品的需求。这些改进预计将提高 PoC 分子诊断测试的可用性，从而提供快速有效的测试结果。

公司正在透过收购中小型公司来扩大产品系列。例如，2021年3月，Hologic宣布以1.59亿美元收购Diagenode，这是一家分子诊断公司，拥有多种PCR仪器，能够检测30多种细菌。同样，2021年4月，F. Hoffmann-La Roche Ltd.以每股24.05美元现金收购GenMark Diagnostics, Inc.，持有GenMark Diagnostics, Inc.约82.89%的股份。 GenMark Diagnostics, Inc. 拥有 eSensor XT-8 和 ePlex 等专有技术，可用于开发传染病检查（包括血流感染疾病）的检测。

其他活动包括加强研发力度，开发针对新兴疾病的套件，并与其他套件製造公司达成协议，扩大 Masu 的即时PCR选项范围。这包括罗氏诊断公司在 Cobas 4800 上采用 Cobas HPV 检测方法。 Cepheid 在 GeneXpert 平台上采用结核病检测 Xpert 检测就是此类进步的一个例子。这些进步预计将推动全球分子诊断市场的发展。

分子诊断市场报告亮点

  • 试剂细分市场占据主导地位，2024年占全球销售额的65.44%。由于其在研究和临床环境中的广泛应用以及新测试的日益采用，预计在整个预测期内将保持其主导地位。
  • 聚合酵素链锁反应技术领域在2024年占据最大的收益占有率。这是因为它用于检测 COVID-19 和其他感染疾病。
  • 2024年感染疾病领域占收益占有率最大。越来越多地使用分子检测（尤其是 PCR 检测）来诊断 COVID-19，显着增加了该细分市场的份额。
  • 由于中心实验室进行了大量的新冠病毒检测和其他医疗保健适应症检测，中心实验室细分市场将在 2024 年占据行业主导地位。
  • 北美市场占据主导地位，2024 年市占率为 40.95%。这是因为感染疾病和慢性病流行病学的上升正在推动公司推出新的分子诊断测试，从而促进市场成长。
  • 由于市场渗透率的提高、当地市场参与者扩大采用新型诊断技术的倡议以及未满足的市场需求，预计亚太地区从 2025 年到 2030 年将呈现显着增长。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 分子诊断的变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 分子诊断分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 分子诊断市场：按产品細項分析，2018-2030 年（百万美元）

  • 定义和范围
  • 2024/2030 年产品市场占有率分析
  • 分子诊断市场（按产品），2018-2030
  • 2018-2030年市场规模/预测与趋势分析

第五章分子诊断市场：細項分析，按测试地点，2018-2030（百万美元）

  • 定义和范围
  • 2024 年和 2030 年测试站点市场占有率分析
  • 全球分子诊断市场（按测试地点），2018-2030
  • 2018-2030年市场规模/预测与趋势分析

第 6 章 分子诊断市场：按技术分類的細項分析，2018-2030 年（百万美元）

  • 定义和范围
  • 2024 年和 2030 年技术市场占有率分析
  • 全球分子诊断市场（按技术），2018-2030
  • 2018-2030年市场规模/预测与趋势分析

第 7 章 分子诊断市场：2018-2030 年按应用細項分析（百万美元）

  • 定义和范围
  • 2024/2030 年应用市场占有率分析
  • 全球分子诊断市场（按应用），2018-2030
  • 2018-2030年市场规模/预测与趋势分析

第八章分子诊断市场：区域估计与趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 比利时
    • 瑞士
    • 荷兰
    • 波兰
    • 奥地利
    • 丹麦
    • 瑞典
    • 土耳其
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 泰国
    • 斯里兰卡
    • 马来西亚
    • 越南
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 约旦
    • 阿拉伯聯合大公国
    • 卡达
    • 埃及
    • 科威特

第9章 竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • BD
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Agilent Technologies, Inc.
    • Danaher
    • Hologic Inc.（Gen Probe）
    • Illumina, Inc.
    • Grifols
    • QIAGEN
    • F. Hoffmann-La Roche, Ltd.
    • Siemens Healthineers AG
    • Sysmex Corporatio
Product Code: 978-1-68038-086-6

Molecular Diagnostics Market Growth & Trends:

The global molecular diagnostics market size is estimated to reach USD 33.08 billion by 2030, expanding at a CAGR of 3.97% from 2025 to 2030, according to a new report by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

Molecular Diagnostics Market Report Highlights:

  • The reagents segment dominated the market and accounted for a share of 65.44% of the global revenue in 2024. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.
  • The polymerase chain reaction technology segment accounted for the largest revenue share in 2024. This is attributed to its use in detecting COVID-19 and other infectious diseases.
  • The infectious diseases segment accounted for the largest revenue share in 2024. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.
  • The central laboratories segment dominated the industry in 2024 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.
  • North America dominated the market and accounted for a 40.95% share in 2024. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.
  • Asia Pacific is anticipated to exhibit significant growth from 2025 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Molecular Diagnostics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in geriatric population
      • 3.2.1.2. Introduction of technologically advanced products
      • 3.2.1.3. Increase in demand for point-of-care Testing
      • 3.2.1.4. Growing prevalence of target diseases
      • 3.2.1.5. Increasing external funding for R&D
      • 3.2.1.6. Outbreak of COVID-19
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of ambiguous regulatory framework
      • 3.2.2.2. High prices of molecular diagnostics tests
  • 3.3. Molecular Diagnostics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Molecular Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2030
  • 4.3. Molecular Diagnostics Market, by Product, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Instruments
      • 4.4.1.1. Instruments market, 2018 - 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Reagents market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Molecular Diagnostics Market: Segment Analysis, By Test Location, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Test Location Market Share Analysis, 2024 & 2030
  • 5.3. Global Molecular Diagnostics Market, by Test Location, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Point of care
      • 5.4.1.1. Point of care market, 2018 - 2030 (USD Million)
    • 5.4.2. Self test or OTC
      • 5.4.2.1. Self test or OTC market, 2018 - 2030 (USD Million)
    • 5.4.3. Central laboratories
      • 5.4.3.1. Central laboratories market, 2018 - 2030 (USD Million)

Chapter 6. Molecular Diagnostics Market: Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. Technology Market Share Analysis, 2024 & 2030
  • 6.3. Global Molecular Diagnostics Market, by Technology, 2018 to 2030
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.4.1. PCR
      • 6.4.1.1. PCR market, 2018 - 2030 (USD Million)
      • 6.4.1.2. By procedure
        • 6.4.1.2.1. Nucleic acid extraction
          • 6.4.1.2.1.1. Nucleic acid extraction market, 2018 - 2030 (USD Million)
        • 6.4.1.2.2. Others
          • 6.4.1.2.2.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.1.3. By type
        • 6.4.1.3.1. Multiplex
          • 6.4.1.3.1.1. Multiplex market, 2018 - 2030 (USD Million)
        • 6.4.1.3.2. Others
          • 6.4.1.3.2.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.1.4. By product
        • 6.4.1.4.1. Instruments
          • 6.4.1.4.1.1. Instruments market, 2018 - 2030 (USD Million)
        • 6.4.1.4.2. Reagents
          • 6.4.1.4.2.1. Reagents market, 2018 - 2030 (USD Million)
        • 6.4.1.4.3. Others
          • 6.4.1.4.3.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.2. ISH
      • 6.4.2.1. ISH market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Instruments
        • 6.4.2.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.2.3. Reagents
        • 6.4.2.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.2.4. Others
        • 6.4.2.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.3. INAAT
      • 6.4.3.1. INAAT market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Instruments
        • 6.4.3.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.3.3. Reagents
        • 6.4.3.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.3.4. Others
        • 6.4.3.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.4. Chips and microarrays
      • 6.4.4.1. Chips and microarrays market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Instruments
        • 6.4.4.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.4.3. Reagents
        • 6.4.4.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.4.4. Others
        • 6.4.4.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.5. Mass spectrometry
      • 6.4.5.1. Mass spectrometry market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Instruments
        • 6.4.5.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.5.3. Reagents
        • 6.4.5.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.5.4. Others
        • 6.4.5.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.6. Sequencing
      • 6.4.6.1. Sequencing market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Instruments
        • 6.4.6.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.6.3. Reagents
        • 6.4.6.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.6.4. Others
        • 6.4.6.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.7. TMA
      • 6.4.7.1. TMA market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Instruments
        • 6.4.7.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.7.3. Reagents
        • 6.4.7.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.7.4. Others
        • 6.4.7.4.1. Others market, 2018 - 2030 (USD Million)
    • 6.4.8. Others
      • 6.4.8.1. Others market, 2018 - 2030 (USD Million)
      • 6.4.8.2. Instruments
        • 6.4.8.2.1. Instruments market, 2018 - 2030 (USD Million)
      • 6.4.8.3. Reagents
        • 6.4.8.3.1. Reagents market, 2018 - 2030 (USD Million)
      • 6.4.8.4. Others
        • 6.4.8.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Molecular Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1. Definition and Scope
  • 7.2. Application Market Share Analysis, 2024 & 2030
  • 7.3. Global Molecular Diagnostics Market, by Application,2018 to 2030
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 7.4.1. Oncology
      • 7.4.1.1. Oncology market, 2018 - 2030 (USD Million)
      • 7.4.1.2. Breast cancer
        • 7.4.1.2.1. Breast cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.3. Prostate cancer
        • 7.4.1.3.1. Prostate cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.4. Colorectal cancer
        • 7.4.1.4.1. Colorectal cancer market, 2018 - 2030 (USD Million)
      • 7.4.1.5. Cervical
        • 7.4.1.5.1. Cervical market, 2018 - 2030 (USD Million)
      • 7.4.1.6. Kidney
        • 7.4.1.6.1. Kidney market, 2018 - 2030 (USD Million)
      • 7.4.1.7. Liver
        • 7.4.1.7.1. Liver market, 2018 - 2030 (USD Million)
      • 7.4.1.8. Blood
        • 7.4.1.8.1. Blood market, 2018 - 2030 (USD Million)
      • 7.4.1.9. Lung
        • 7.4.1.9.1. Lung market, 2018 - 2030 (USD Million)
      • 7.4.1.10. Other
        • 7.4.1.10.1. Other market, 2018 - 2030 (USD Million)
    • 7.4.2. Pharmacogenomics
      • 7.4.2.1. Pharmacogenomics market, 2018 - 2030 (USD Million)
    • 7.4.3. Infectious disease
      • 7.4.3.1. Infectious disease market, 2018 - 2030 (USD Million)
      • 7.4.3.2. MRSA
        • 7.4.3.2.1. MRSA market, 2018 - 2030 (USD Million)
      • 7.4.3.3. Clostridium difficile
        • 7.4.3.3.1. Clostridium difficile market, 2018 - 2030 (USD Million)
      • 7.4.3.4. Vancomycin-resistant enterococci
        • 7.4.3.4.1. Vancomycin-resistant enterococci market, 2018 - 2030 (USD Million)
      • 7.4.3.5. Carbapenem-resistant bacteria testing
        • 7.4.3.5.1. Carbapenem-resistant bacteria testing market, 2018 - 2030 (USD Million)
      • 7.4.3.6. Flu
        • 7.4.3.6.1. Flu market, 2018 - 2030 (USD Million)
      • 7.4.3.7. Respiratory syncytial virus (RSV)
        • 7.4.3.7.1. Respiratory syncytial virus (RSV) market, 2018 - 2030 (USD Million)
      • 7.4.3.8. Candida
        • 7.4.3.8.1. Candida market, 2018 - 2030 (USD Million)
      • 7.4.3.9. Tuberculosis and drug-resistant TB
        • 7.4.3.9.1. Tuberculosis and drug-resistant TB market, 2018 - 2030 (USD Million)
      • 7.4.3.10. Meningitis
        • 7.4.3.10.1. Meningitis market, 2018 - 2030 (USD Million)
      • 7.4.3.11. Gastro-intestinal panel testing
        • 7.4.3.11.1. Gastro-intestinal panel testing market, 2018 - 2030 (USD Million)
      • 7.4.3.12. Chlamydia
        • 7.4.3.12.1. Chlamydia market, 2018 - 2030 (USD Million)
      • 7.4.3.13. Gonorrhea
        • 7.4.3.13.1. Gonorrhea market, 2018 - 2030 (USD Million)
      • 7.4.3.14. HIV
        • 7.4.3.14.1. HIV market, 2018 - 2030 (USD Million)
      • 7.4.3.15. Hepatitis C
        • 7.4.3.15.1. Hepatitis C market, 2018 - 2030 (USD Million)
      • 7.4.3.16. Hepatitis B
        • 7.4.3.16.1. Hepatitis B market, 2018 - 2030 (USD Million)
      • 7.4.3.17. Other infectious diseases
        • 7.4.3.17.1. Other infectious diseases market, 2018 - 2030 (USD Million)
    • 7.4.4. Genetic testing
      • 7.4.4.1. Genetic testing market, 2018 - 2030 (USD Million)
      • 7.4.4.2. Newborn screening
        • 7.4.4.2.1. Newborn screening market, 2018 - 2030 (USD Million)
      • 7.4.4.3. Predictive and presymptomatic testing
        • 7.4.4.3.1. Predictive and presymptomatic testing market, 2018 - 2030 (USD Million)
      • 7.4.4.4. Others
        • 7.4.4.4.1. Others market, 2018 - 2030 (USD Million)
    • 7.4.5. Neurological disease
      • 7.4.5.1. Neurological disease market, 2018 - 2030 (USD Million)
    • 7.4.6. Cardiovascular disease
      • 7.4.6.1. Cardiovascular disease market, 2018 - 2030 (USD Million)
    • 7.4.7. Microbiology
      • 7.4.7.1. Microbiology market, 2018 - 2030 (USD Million)
    • 7.4.8. Others
      • 7.4.8.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Molecular Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Spain
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.6. Belgium
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Belgium market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.7. Switzerland
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Switzerland market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.8. Netherlands
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Netherlands market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.9. Poland
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Regulatory framework/ reimbursement structure
      • 8.4.9.3. Competitive scenario
      • 8.4.9.4. Poland market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.10. Austria
      • 8.4.10.1. Key country dynamics
      • 8.4.10.2. Regulatory framework/ reimbursement structure
      • 8.4.10.3. Competitive scenario
      • 8.4.10.4. Austria market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.11. Denmark
      • 8.4.11.1. Key country dynamics
      • 8.4.11.2. Regulatory framework/ reimbursement structure
      • 8.4.11.3. Competitive scenario
      • 8.4.11.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.12. Sweden
      • 8.4.12.1. Key country dynamics
      • 8.4.12.2. Regulatory framework/ reimbursement structure
      • 8.4.12.3. Competitive scenario
      • 8.4.12.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.13. Turkey
      • 8.4.13.1. Key country dynamics
      • 8.4.13.2. Regulatory framework/ reimbursement structure
      • 8.4.13.3. Competitive scenario
      • 8.4.13.4. Turkey market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.14. Norway
      • 8.4.14.1. Key country dynamics
      • 8.4.14.2. Regulatory framework/ reimbursement structure
      • 8.4.14.3. Competitive scenario
      • 8.4.14.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. China
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.6. Sri Lanka
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Sri Lanka market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.7. Malaysia
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Regulatory framework/ reimbursement structure
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Malaysia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.8. Vietnam
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Regulatory framework/ reimbursement structure
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Vietnam market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.9. Singapore
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Regulatory framework/ reimbursement structure
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Singapore market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Colombia
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Colombia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. Chile
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Chile market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.4. Peru
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Peru market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.5. Argentina
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. Jordan
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Jordan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. Qatar
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. Qatar market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.6. Egypt
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Egypt market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.7. Kuwait
      • 8.7.7.1. Key country dynamics
      • 8.7.7.2. Regulatory framework/ reimbursement structure
      • 8.7.7.3. Competitive scenario
      • 8.7.7.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Recent Developments & Impact Analysis by Key Market Participants
  • 9.3. Company Market Share Analysis, 2024
  • 9.4. Key Company Profiles
    • 9.4.1. BD
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. BIOMERIEUX
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Bio-Rad Laboratories, Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Agilent Technologies, Inc.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Hologic Inc. (Gen Probe)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Illumina, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Grifols
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. QIAGEN
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. F. Hoffmann-La Roche, Ltd.
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Siemens Healthineers AG
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Sysmex Corporatio

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 6 North America molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 7 North America molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. molecular diagnostics, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. molecular diagnostics, by test location, 2018 - 2030 (USD Million)
  • Table 10 U.S. molecular diagnostics, by technology, 2018 - 2030 (USD Million)
  • Table 11 U.S. molecular diagnostics, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 14 Canada molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 15 Canada molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Mexico molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 18 Mexico molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Mexico molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Europe molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 23 Europe molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Europe molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 25 UK molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 27 UK molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 UK molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Germany molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 Germany molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 31 Germany molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 32 Germany molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 France molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 France molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 35 France molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 France molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Spain molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 39 Spain molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Spain molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 43 Italy molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Italy molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 45 Belgium molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Belgium molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 47 Belgium molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Belgium molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Switzerland molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Switzerland molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 51 Switzerland molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Switzerland molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 53 Netherlands molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Netherlands molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 55 Netherlands molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Netherlands molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 57 Poland molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Poland molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 59 Poland molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 60 Poland molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Austria molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Austria molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 63 Austria molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Austria molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Denmark molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 Denmark molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 67 Denmark molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Denmark molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Sweden molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Sweden molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 71 Sweden molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Sweden molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 73 Turkey molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 74 Turkey molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 75 Turkey molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 Turkey molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 Norway molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 78 Norway molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 79 Norway molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Norway molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 82 Asia Pacific molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Asia Pacific molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 84 Asia Pacific molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 85 Asia Pacific molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 86 Japan molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Japan molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 88 Japan molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Japan molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 90 China molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 91 China molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 92 China molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 China molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 India molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 95 India molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 96 India molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 India molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Australia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Australia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 100 Australia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Australia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 New Zealand molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 103 New Zealand molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 104 New Zealand molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 105 New Zealand molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 106 Sri Lanka molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 107 Sri Lanka molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 108 Sri Lanka molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Sri Lanka molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 110 Malaysia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 111 Malaysia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 112 Malaysia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 113 Malaysia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 114 Thailand molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 115 Thailand molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 116 Thailand molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 117 Thailand molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 118 Vietnam molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 119 Vietnam molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 120 Vietnam molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 121 Vietnam molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 122 Singapore molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 123 Singapore molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 124 Singapore molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Singapore molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 126 Latin America molecular diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 127 Latin America molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 128 Latin America molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 129 Latin America molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 130 Latin America molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 131 Brazil molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 132 Brazil molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 133 Brazil molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 134 Brazil molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 135 Colombia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 136 Colombia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 137 Colombia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 138 Colombia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 139 Chile molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 140 Chile molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 141 Chile molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 142 Chile molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 143 Peru molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 144 Peru molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 145 Peru molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 146 Peru molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 147 Argentina molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 148 Argentina molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 149 Argentina molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 150 Argentina molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 151 MEA molecular diagnostics market, by country 2018 - 2030 (USD Million)
  • Table 152 MEA molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 153 MEA molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 154 MEA molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 155 MEA molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 156 South Africa molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 157 South Africa molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 158 South Africa molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 159 South Africa molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 160 Saudi Arabia molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 161 Saudi Arabia molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 162 Saudi Arabia molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 163 Saudi Arabia molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 164 Jordan molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 165 Jordan molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 166 Jordan molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 167 Jordan molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 168 UAE molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 169 UAE molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 170 UAE molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 171 UAE molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 172 Qatar molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 173 Qatar molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 174 Qatar molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 175 Qatar molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 176 Kuwait molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 177 Kuwait molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 178 Kuwait molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 179 Kuwait molecular diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 180 Egypt molecular diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 181 Egypt molecular diagnostics market, by test location, 2018 - 2030 (USD Million)
  • Table 182 Egypt molecular diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 183 Egypt molecular diagnostics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Molecular diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Product and test location segment snapshot
  • Fig. 11 Technology segment snapshot
  • Fig. 12 Application segment snapshot
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Molecular diagnostics market value, 2024 (USD Billion)
  • Fig. 15 Market dynamics
  • Fig. 16 Global number of people aged over 60 years or over (thousands) in 2024
  • Fig. 17 Global estimated cancer incidence in different elderly age groups, 2022 (Million)
  • Fig. 18 General trend shifts from laboratory to point-of-care
  • Fig. 19 Incidence of cancer in North America, 2022-2050
  • Fig. 20 Incidence of cancer in Europe, 2022-2050
  • Fig. 21 Incidence of cancer in Asia Pacific, 2022-2050
  • Fig. 22 Incidence of cancer in Latin America, 2022-2050
  • Fig. 23 Incidence of cancer in Africa, 2022-2050
  • Fig. 24 Incidence of cancer in Oceania, 2022-2050
  • Fig. 25 Sources of healthcare financing according to country income, 2020 (%)
  • Fig. 26 Porter's five forces analysis
  • Fig. 27 PESTLE analysis
  • Fig. 28 Molecular diagnostics market: Product outlook and key takeaways
  • Fig. 29 Molecular diagnostics market: Product movement analysis
  • Fig. 30 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Molecular diagnostics market: Technology outlook and key takeaways
  • Fig. 34 Molecular diagnostics market: Technology movement analysis
  • Fig. 35 PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Multiplex PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Other PCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Nucleic acid extraction market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 INAAT market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Transcription mediated amplification (TMA) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Molecular diagnostics market: Application outlook and key takeaways
  • Fig. 72 Molecular diagnostics market: Application movement analysis
  • Fig. 73 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Breast cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Prostate cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Colorectal cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Cervical cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Kidney cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Liver cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Lung cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Blood cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Other cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Pharmacogenomics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Methicillin-resistant staphylococcus aureus (MRSA) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Vancomycin-resistant enterococci (VRE) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Carbapenem-resistant bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Flu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Respiratory syncytial virus (RSV) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Tuberculosis and drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Meningitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Gastrointestinal panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 97 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Other infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 101 Genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Newborn screening market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Predictive and presymptomatic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Other genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Neurological disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 106 Cardiovascular disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 Molecular diagnostics market: Test location outlook and key takeaways
  • Fig. 110 Molecular diagnostics market: Test location movement analysis
  • Fig. 111 Point of care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Self-test or over-the-counter market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Central laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 114 Molecular diagnostics market revenue, by region, 2024 & 2030 (USD Million)
  • Fig. 115 Regional marketplace: Key takeaways
  • Fig. 116 Regional marketplace: Key takeaways
  • Fig. 117 North America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Key country dynamics
  • Fig. 119 Estimated cancer incidence in U.S., 2024 - 2030
  • Fig. 120 U.S. molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Key country dynamics
  • Fig. 122 Estimated cancer incidence in Canada, 2024 - 2030
  • Fig. 123 Canada molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 124 Key country dynamics
  • Fig. 125 Estimated cancer incidence in Mexico, 2024 - 2030
  • Fig. 126 Mexico molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Europe molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 128 Key country dynamics
  • Fig. 129 Estimated cancer incidence in UK, 2024 - 2030
  • Fig. 130 UK molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Key country dynamics
  • Fig. 132 Estimated cancer incidence in Germany, 2024 - 2030
  • Fig. 133 Germany molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 134 Key country dynamics
  • Fig. 135 Estimated cancer incidence in France, 2024 - 2030
  • Fig. 136 France molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 Estimated cancer incidence in Spain, 2024 - 2030
  • Fig. 139 Spain molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 140 Key country dynamics
  • Fig. 141 Estimated cancer incidence in Italy, 2024 - 2030
  • Fig. 142 Italy molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Estimated cancer incidence in Denmark, 2024 - 2030
  • Fig. 145 Denmark molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 146 Key country dynamics
  • Fig. 147 Sweden molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 148 Key country dynamics
  • Fig. 149 Norway molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 150 Key country dynamics
  • Fig. 151 Belgium molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 152 Key country dynamics
  • Fig. 153 Switzerland molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 154 Key country dynamics
  • Fig. 155 Netherlands molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 156 Key country dynamics
  • Fig. 157 Poland molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 158 Key country dynamics
  • Fig. 159 Austria molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 160 Key country dynamics
  • Fig. 161 Turkey molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 162 Rest of Europe molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 163 Asia Pacific molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Key country dynamics
  • Fig. 165 Japan molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Key country dynamics
  • Fig. 167 China molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Key country dynamics
  • Fig. 169 India molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 170 Key country dynamics
  • Fig. 171 Australia molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 172 Key country dynamics
  • Fig. 173 Thailand molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 174 Key country dynamics
  • Fig. 175 New Zealand molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 176 Key country dynamics
  • Fig. 177 Sri Lanka molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 178 Key country dynamics
  • Fig. 179 Malaysia molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 180 Key country dynamics
  • Fig. 181 Vietnam molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 182 Key country dynamics
  • Fig. 183 Singapore molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 184 Rest of Asia Pacific molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 185 Latin America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 186 Key country dynamics
  • Fig. 187 Brazil molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 188 Key country dynamics
  • Fig. 189 Argentina molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 190 Key country dynamics
  • Fig. 191 Colombia molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 192 Key country dynamics
  • Fig. 193 Chile molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 194 Key country dynamics
  • Fig. 195 Peru molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 196 Rest of Latin America molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 197 MEA molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 198 Key country dynamics
  • Fig. 199 Estimated cancer incidence in South Africa, 2024 - 2030
  • Fig. 200 South Africa molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 201 Key country dynamics
  • Fig. 202 Estimated cancer incidence in Saudi Arabia, 2024 - 2030
  • Fig. 203 Saudi Arabia molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 204 Key country dynamics
  • Fig. 205 Estimated new cancer cases in UAE, 2024 - 2030
  • Fig. 206 UAE molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 207 Key country dynamics
  • Fig. 208 Kuwait molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 209 Key country dynamics
  • Fig. 210 Jordan molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 211 Key country dynamics
  • Fig. 212 Qatar molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 213 Key country dynamics
  • Fig. 214 Egypt molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 215 Rest of MEA molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 216 Key company categorization
  • Fig. 217 Global company market share analysis for molecular diagnostics, 2024
  • Fig. 218 North America company market share analysis for molecular diagnostics, 2024
  • Fig. 219 Europe company market share analysis for molecular diagnostics, 2024
  • Fig. 220 Asia Pacific company market share analysis for molecular diagnostics, 2024
  • Fig. 221 Latin America company market share analysis for molecular diagnostics, 2024
  • Fig. 222 MEA company market share analysis for molecular diagnostics, 2024
  • Fig. 223 Strategy mapping